FGF2-induced effects on transcriptome associated with regeneration competence in adult human fibroblasts

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Kashpur, Olga ^a   LaPointe, David ^b   Ambady, Sakthikumar ^c   Ryder, Elizabeth F ^a   Dominko, Tanja ^a  

^a Life Science and Bioengineering Center   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Worcester Polytechnic Institute   (United States)

Author keywords

Fibroblast growth factor (FGF2); Human fibroblasts; Regeneration; Transcriptome; Wound healing

Indexed keywords

ADAMTS1 PROTEIN; ALPHA ACTININ 1; ALPHA2 INTEGRIN; BETA3 INTEGRIN; CADHERIN; CD18 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN; CXCL1 CHEMOKINE; CYTOSKELETON PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE 1; PROSTAGLANDIN SYNTHASE; SCATTER FACTOR; SCLEROPROTEIN; STAT3 PROTEIN; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA3; CYTOKINE; CYTOKINE RECEPTOR;

ADULT; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PHENOTYPE; SKIN FIBROBLAST; CELL PROLIFERATION; CYTOLOGY; CYTOSKELETON; DRUG EFFECTS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; METABOLISM; REGENERATION; SIGNAL TRANSDUCTION; WOUND HEALING;

ADULT; CELL ADHESION MOLECULES; CELL PROLIFERATION; CYTOKINES; CYTOSKELETON; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMANS; RECEPTORS, CYTOKINE; REGENERATION; SIGNAL TRANSDUCTION; TRANSCRIPTOME; WOUND HEALING;

EID: 84884537159     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-656     Document Type: Article

References (74)

1. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002, 13(6):1977-2000. 10.1091/mbc.02-02-0030., 117619, 12058064.
2. Cooper S, Shedden K. Microarray analysis of gene expression during the cell cycle. Cell Chromosome 2003, 2(1):1. 10.1186/1475-9268-2-1, 239863, 14577836.
3. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, Sapinoso L, Hampton G, Elledge SJ, Davis RW, Lockhart DJ. Transcriptional regulation and function during the human cell cycle. Nat Gene 2001, 27(1):48-54.
4. Forsyth NR, Kay A, Hampson K, Downing A, Talbot R, McWhir J. Transcriptome alterations due to physiological normoxic (2% O2) culture of human embryonic stem cells. Regen Med 2008, 3(6):817-833. 10.2217/17460751.3.6.817, 18947306.
5. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005, 23(9):1357-1366. 10.1634/stemcells.2005-0094, 16081661.
6. Derda R, Li L, Orner BP, Lewis RL, Thomson JA, Kiessling LL. Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem Biol 2007, 2(5):347-355. 10.1021/cb700032u, 17480050.
7. Rodin S, Domogatskaya A, Strom S, Hansson EM, Chien KR, Inzunza J, Hovatta O, Tryggvason K. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 2010, 28(6):611-615. 10.1038/nbt.1620, 20512123.
8. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001, 19(10):971-974. 10.1038/nbt1001-971, 11581665.
9. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA. Feeder-independent culture of human embryonic stem cells. Nat Methods 2006, 3(8):637-646. 10.1038/nmeth902, 16862139.
10. Braam SR, Zeinstra L, Litjens S, Ward-van Oostwaard D, van den Brink S, van Laake L, Lebrin F, Kats P, Hochstenbach R, Passier R, et al. Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 2008, 26(9):2257-2265. 10.1634/stemcells.2008-0291, 18599809.
11. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Method 2011, 8(5):424-429.
12. Rowland TJ, Miller LM, Blaschke AJ, Doss EL, Bonham AJ, Hikita ST, Johnson LV, Clegg DO. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev 2010, 19(8):1231-1240. 10.1089/scd.2009.0328, 19811096.
13. Chen W, Villa-Diaz LG, Sun Y, Weng S, Kim JK, Lam RH, Han L, Fan R, Krebsbach PH, Fu J. Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano 2012, 6(5):4094-4103. 10.1021/nn3004923, 3358529, 22486594.
14. Sun Y, Villa-Diaz LG, Lam RH, Chen W, Krebsbach PH, Fu J. Mechanics regulates fate decisions of human embryonic stem cells. PLoS One 2012, 7(5):e37178. 10.1371/journal.pone.0037178, 3353896, 22615930.
15. Ono I, Akasaka Y, Kikuchi R, Sakemoto A, Kamiya T, Yamashita T, Jimbow K. Basic fibroblast growth factor reduces scar formation in acute incisional wounds. Wound Repair Regen 2007, 15(5):617-623. 10.1111/j.1524-475X.2007.00293.x, 17971006.
16. Eto H, Suga H, Aoi N, Kato H, Doi K, Kuno S, Tabata Y, Yoshimura K. Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression. Lab Invest 2012, 92(2):214-223. 10.1038/labinvest.2011.127, 21946856.
17. Xie J, Bian H, Qi S, Xu Y, Tang J, Li T, Liu X. Effects of basic fibroblast growth factor on the expression of extracellular matrix and matrix metalloproteinase-1 in wound healing. Clin Exp Dermatol 2008, 33(2):176-182. 10.1111/j.1365-2230.2007.02573.x, 18257838.
18. Page RL, Ambady S, Holmes WF, Vilner L, Kole D, Kashpur O, Huntress V, Vojtic I, Whitton H, Dominko T. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells 2009, 11(3):417-426. 10.1089/clo.2009.0015, 2925031, 19622035.
19. Page RL, Malcuit C, Vilner L, Vojtic I, Shaw S, Hedblom E, Hu J, Pins GD, Rolle MW, Dominko T. Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads. Tissue Eng Part A 2011, 17(21-22):2629-2640.
20. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008, 453(7193):314-321. 10.1038/nature07039, 18480812.
21. Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep. J Cell Sci 2004, 117(Pt 5):667-675.
22. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009, 122(Pt 18):3209-3213. 2736861, 19726630.
23. Li W, Fan J, Chen M, Guan S, Sawcer D, Bokoch GM, Woodley DT. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol Biol Cell 2004, 15(1):294-309. 307548, 14595114.
24. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997, 276(5309):75-81. 10.1126/science.276.5309.75, 9082989.
25. Eckes B, Nischt R, Krieg T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis tissue repair 2010, 3:4. 10.1186/1755-1536-3-4, 2855519, 20222960.
26. Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002, 13(10):3546-3559. 10.1091/mbc.E02-01-0048, 129965, 12388756.
27. Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 2002, 277(40):37377-37381. 10.1074/jbc.M206286200, 12145303.
28. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J cell sci 2003, 116(Pt 16):3269-3276.
29. Rossier O, Octeau V, Sibarita JB, Leduc C, Tessier B, Nair D, Gatterdam V, Destaing O, Albiges-Rizo C, Tampe R, et al. Integrins beta1 and beta3 exhibit distinct dynamic nanoscale organizations inside focal adhesions. Nat Cell Biol 2012, 14(10):1057-1067. 10.1038/ncb2588, 23023225.
30. Huttenlocher A, Horwitz AR. Integrins in cell migration. Cold Spring Harb Perspect Biol 2011, 3(9):a005074. 10.1101/cshperspect.a005074, 3181029, 21885598.
31. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010, 11(9):633-643. 10.1038/nrm2957, 2992881, 20729930.
32. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010, 188(1):11-19. 10.1083/jcb.200909003, 2812848, 19951899.
33. Walpita D, Hay E. Studying actin-dependent processes in tissue culture. N Rev Mol Cell Biol 2002, 3(2):137-141.
34. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8(3):221-233. 10.1038/nrm2125, 2760082, 17318226.
35. Newberry EP, Willis D, Latifi T, Boudreaux JM, Towler DA. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element. Mol Endocrinol 1997, 11(8):1129-1144. 10.1210/me.11.8.1129, 9212060.
36. Kaar JL, Li Y, Blair HC, Asche G, Koepsel RR, Huard J, Russell AJ. Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomaterialia 2008, 4(5):1411-1420. 10.1016/j.actbio.2008.03.010, 18440885.
37. Bedair H, Liu TT, Kaar JL, Badlani S, Russell AJ, Li Y, Huard J. Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol 2007, 102(6):2338-2345. 10.1152/japplphysiol.00670.2006, 17551103.
38. Bellayr I, Holden K, Mu X, Pan H, Li Y. Matrix metalloproteinase inhibition negatively affects muscle stem cell behavior. Int J Clin Exp Pathol 2013, 6(2):124-141. 3544228, 23329998.
39. Wang W, Pan H, Murray K, Jefferson BS, Li Y. Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am J Pathol 2009, 174(2):541-549. 10.2353/ajpath.2009.080509, 2630562, 19147819.
40. Allen DL, Teitelbaum DH, Kurachi K. Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol Cell Physiol 2003, 284(4):C805-815. 10.1152/ajpcell.00215.2002, 12466149.
41. Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari VM, Heino J. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J Biol Chem 1995, 270(22):13548-13552. 10.1074/jbc.270.22.13548, 7768957.
42. Vihinen P, Riikonen T, Laine A, Heino J. Integrin alpha 2 beta 1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen. Cell Growth Differ 1996, 7(4):439-447.
43. Bullard KM, Mudgett J, Scheuenstuhl H, Hunt TK, Banda MJ. Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. J Surg Res 1999, 84(1):31-34. 10.1006/jsre.1999.5599, 10334885.
44. Pintucci G, Yu PJ, Sharony R, Baumann FG, Saponara F, Frasca A, Galloway AC, Moscatelli D, Mignatti P. Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2-/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). J Cell Biochem 2003, 90(5):1015-1025. 10.1002/jcb.10721, 14624461.
45. Vinarsky V, Atkinson DL, Stevenson TJ, Keating MT, Odelberg SJ. Normal newt limb regeneration requires matrix metalloproteinase function. Dev Biol 2005, 279(1):86-98. 10.1016/j.ydbio.2004.12.003, 15708560.
46. Stevenson TJ, Vinarsky V, Atkinson DL, Keating MT, Odelberg SJ. Tissue inhibitor of metalloproteinase 1 regulates matrix metalloproteinase activity during newt limb regeneration. Dev Dyn 2006, 235(3):606-616. 10.1002/dvdy.20654, 16372340.
47. Santosh N, Windsor LJ, Mahmoudi BS, Li B, Zhang W, Chernoff EA, Rao N, Stocum DL, Song F. Matrix metalloproteinase expression during blastema formation in regeneration-competent versus regeneration-deficient amphibian limbs. Dev Dyn 2011, 240(5):1127-1141. 10.1002/dvdy.22503, 21128310.
48. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J 2005, 386(Pt 1):15-27. 1134762, 15554875.
49. Lin RY, Sullivan KM, Argenta PA, Meuli M, Lorenz HP, Adzick NS. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Annals Surg 1995, 222(2):146-154.
50. Greber B, Lehrach H, Adjaye J. Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells 2007, 25(2):455-464. 10.1634/stemcells.2006-0476, 17038665.
51. Chen L, Arbieva ZH, Guo S, Marucha PT, Mustoe TA, DiPietro LA. Positional differences in the wound transcriptome of skin and oral mucosa. BMC Genom 2010, 11:471.
52. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 2000, 12(6):671-676. 10.1006/cyto.1999.0598, 10843743.
53. Liechty KW, Crombleholme TM, Cass DL, Martin B, Adzick NS. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 1998, 77(1):80-84. 10.1006/jsre.1998.5345, 9698538.
54. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR. Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. Curr Biol CB 2003, 13(13):1122-1128.
55. Wulff BC, Parent AE, Meleski MA, DiPietro LA, Schrementi ME, Wilgus TA. Mast cells contribute to scar formation during fetal wound healing. J Invest Dermatol 2012, 132(2):458-465. 10.1038/jid.2011.324, 3258379, 21993557.
56. Lorenz HP, Longaker MT, Perkocha LA, Jennings RW, Harrison MR, Adzick NS. Scarless wound repair: a human fetal skin model. Development 1992, 114(1):253-259.
57. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008, 40(6-7):1334-1347. 2746915, 18083622.
58. Wong VW, Rustad KC, Akaishi S, Sorkin M, Glotzbach JP, Januszyk M, Nelson ER, Levi K, Paterno J, Vial IN, et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med 2012, 18(1):148-152.
59. Roy S, Khanna S, Rink C, Biswas S, Sen CK. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics 2008, 34(2):162-184. 10.1152/physiolgenomics.00045.2008, 2494843, 18460641.
60. Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991, 97(4):686-692.
61. Liu X, Das AM, Seideman J, Griswold D, Afuh CN, Kobayashi T, Abe S, Fang Q, Hashimoto M, Kim H, et al. The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6. Am J Respir Cell Mol Biol 2007, 37(1):121-128. 10.1165/rcmb.2005-0253OC, 17379849.
62. Delrieu I, Arnaud E, Ferjoux G, Bayard F, Faye JC. Overexpression of the FGF-2 24-kDa isoform up-regulates IL-6 transcription in NIH-3T3 cells. FEBS letters 1998, 436(1):17-22. 10.1016/S0014-5793(98)01086-2, 9771886.
63. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2008, 7(1):33-44. 10.1016/j.cmet.2007.11.011, 18177723.
64. McKay BR, De Lisio M, Johnston AP, O'Reilly CE, Phillips SM, Tarnopolsky MA, Parise G. Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS one 2009, 4(6):e6027. 10.1371/journal.pone.0006027, 2696599, 19554087.
65. Toth KG, McKay BR, De Lisio M, Little JP, Tarnopolsky MA, Parise G. IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS one 2011, 6(3):e17392. 10.1371/journal.pone.0017392, 3052298, 21408055.
66. Ray S, Ju X, Sun H, Finnerty CC, Herndon DN, Brasier AR. The IL-6 Trans-Signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic Scar. J Invest Dermatol 2013, 135(5):1212-1220.
67. R Core Team R: A language and environment for statistical computing 2012, Vienna, Austria: R Foundation for Statistical Computing, R Core Team.
68. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
69. Smyth G. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. New York: Springer, Gentleman VC R, Dudoit S, Irizarry R, Huber W.
70. Gordon K, Smyth MR, Natalie T, James W, Wei S. limma: Linear Models for Microarray Data User's Guide (Now Including RNA-Seq Data Analysis) 2012, Melbourne, Australia Bioinformatics Division: The Walter and Eliza Hall Institute of Medical Research, First, 1327694, 16371165.
71. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:1.
72. Benjamini YHY. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995, 57(1):289-300.
73. Deng X. geneListPie: Profiling a gene list into GOslim or KEGG function pie. R package version 1.0 2012,
74. Gentleman SFaR Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23(2):257-258. 10.1093/bioinformatics/btl567, 17098774, Gentleman SFaR.